Provided by Tiger Fintech (Singapore) Pte. Ltd.

Benitec Biopharma

13.59
-0.3050-2.20%
Post-market: 13.590.00000.00%16:00 EDT
Volume:15.40K
Turnover:208.81K
Market Cap:346.47M
PE:-7.02
High:13.81
Open:13.81
Low:13.40
Close:13.90
Loading ...

What Makes Benitec Biopharma (BNTC) a New Buy Stock

Zacks
·
24 Apr

Are Medical Stocks Lagging Ascendis Pharma (ASND) This Year?

Zacks
·
16 Apr

Benitec Biopharma Is Maintained at Market Outperform by JMP Securities

Dow Jones
·
10 Apr

Benitec Biopharma price target raised to $20 from $18 at Citizens JMP

TIPRANKS
·
10 Apr

Promising Clinical Results and Financial Stability Drive Buy Rating for Benitec Biopharma

TIPRANKS
·
10 Apr

Major Investment Alert: Benitec Biopharma Sees Big Buy-In!

TIPRANKS
·
03 Apr

Major Investment Alert: Benitec Biopharma Stock Purchase Shakes the Market!

TIPRANKS
·
29 Mar

Benitec Biopharma prices 1.44M shares at $13.00 in underwritten offering

TIPRANKS
·
26 Mar

Benitec Biopharma Prices $30 Million Equity Offerings

MT Newswires Live
·
25 Mar

Benitec Biopharma Inc - Prices Offering of 2,343,000 Shares

THOMSON REUTERS
·
25 Mar

Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering

GlobeNewswire
·
25 Mar

Benitec Biopharma Price Target Maintained With a $28.00/Share by HC Wainwright & Co.

Dow Jones
·
24 Mar

Promising Clinical Trial Results for Benitec Biopharma’s BB-301 Reinforce Buy Rating

TIPRANKS
·
24 Mar

Benitec Biopharma (BNTC) Receives a Buy from Piper Sandler

TIPRANKS
·
20 Mar

Benitec Biopharma Announces Positive Interim Results for BB-301

TIPRANKS
·
19 Mar

Benitec Biopharma reports interim results for 3 subjects treated with BB-301

TIPRANKS
·
19 Mar

Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated With Bb-301 in Phase 1B/2a Study to Be Presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

THOMSON REUTERS
·
19 Mar

Benitec Biopharma Price Target Maintained With a $18.00/Share by Citizens Capital Markets

Dow Jones
·
18 Mar

Benitec Biopharma (NASDAQ:BNTC) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.
·
10 Mar

Benitec Biopharma to Participate in Upcoming Conferences in March

GlobeNewswire
·
26 Feb